Thomas Foltynie
University College London
H-index: 98
Europe-United Kingdom
Top articles of Thomas Foltynie
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Scaling up GMP-grade dopaminergic cells for Parkinson’s disease | Cell Stem Cell | Thomas Foltynie | 2024/1/4 |
GLP-1 receptor agonism ameliorates Parkinsons disease through modulation of neuronal insulin signalling and glial suppression | bioRxiv | Dilan Athauda James R Evans Laura Sanchez Gurvir Virdi Patricia Lopez Garcia | 2024 |
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials initiative | Richard K Wyse Tom Isaacs Roger A Barker Mark R Cookson Ted M Dawson | 2024/4/5 | |
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease | npj Parkinson's Disease | Poornima Jayadev Menon Sara Sambin Baptiste Criniere-Boizet Thomas Courtin Christelle Tesson | 2024/3/29 |
Embedding Patient Input in Outcome Measures for Long‐Term Disease‐Modifying Parkinson Disease Trials | Movement Disorders | Cristina Gonzalez‐Robles Michèle Bartlett Matthew Burnell Caroline S Clarke Shlomi Haar | 2024/2 |
Medical, surgical, and physical treatments for Parkinson's disease | Tom Foltynie Veronica Bruno Susan Fox Andrea A Kühn Fiona Lindop | 2024/1/20 | |
Modulation of limbic resting-state networks by subthalamic nucleus deep brain stimulation | Network Neuroscience | John Eraifej Joana Cabral Henrique M Fernandes Joshua Kahan Shenghong He | 2023/6/30 |
Brain Oedema Associated with Deep Brain Stimulation Through a Single Directional Contact | Movement disorders clinical practice | Christine Girges Marie T Krüger Harith Akram Jonathan Hyam Patricia Limousin | 2023/9/15 |
Effects of deep brain stimulation frequency on eye movements and cognitive control | npj Parkinson's Disease | André Zacharia Diego Kaski Walid Bouthour Viswas Dayal Matthieu Bereau | 2023/3/31 |
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease | npj Parkinson's Disease | Alejandro Martinez-Carrasco Raquel Real Michael Lawton Hirotaka Iwaki Manuela MX Tan | 2023/8/31 |
Confusion of evidence‐based reviews and guidelines | Movement Disorders | Günther Deuschl Angelo Antonini Joao Costa Katarzyna Śmiłowska Daniela Berg | 2023/3 |
Reducing the number of patients needed in disease modifying trials for parkinsonian disorders | Tom Foltynie | 2023/8 | |
How should we be using biomarkers in trials of disease modification in Parkinson’s disease? | Nirosen Vijiaratnam Thomas Foltynie | 2023/12 | |
Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population | npj Parkinson's Disease | Gareth Morinan Yuriy Dushin Grzegorz Sarapata Samuel Rupprechter Yuwei Peng | 2023/1/27 |
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease | Movement Disorders | Thomas Payne Matthew Appleby Ellen Buckley Linda MA van Gelder Benjamin H Mullish | 2023/8 |
Parkinson's disease tremor differentially responds to levodopa and subthalamic stimulation | Movement Disorders Clinical Practice | Thomas Wirth Francisca Ferreira Nirosen Vijiaratnam Christine Girges Ashkan Pakzad | 2023/11 |
Improving conversations about Parkinson′ s dementia | medRxiv | Ivelina Dobreva Joanne Thomas Anne Marr Ruairiadh O'Connel Moïse Roche | 2023 |
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease | Tom Foltynie Sonia Gandhi Cristina Gonzalez-Robles Marie-Louise Zeissler Georgia Mills | 2023/7 | |
Clinical outcomes after MRI connectivity–guided radiofrequency thalamotomy for tremor | Journal of Neurosurgery | Thomas Wirth Taco Goedemans Ali Rajabian Viswas Dayal Hazem Abuhusain | 2023/10/13 |
Outcome measures for disease-modifying trials in Parkinson’s disease: consensus paper by the EJS ACT-PD multi-arm multi-stage trial initiative | Journal of Parkinson's Disease | Cristina Gonzalez-Robles Rimona S Weil Daniel van Wamelen Michèle Bartlett Matthew Burnell | 2023/1/1 |
